MedTrace Logo

Beverage Hydration Index: Assessment of Four Rehydration Solutions

NCT06272435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-12-16

No results posted yet for this study

Summary

No studies to date to evaluate the effects of the three different liquid IV electrolyte products on the beverage hydration index (BHI). Therefore, the purpose of this study is to determine the impact of three different LIV products (Hydration multiplier, Sugar Free formulation with Amino Acids, and Sugar Free with allulose) on hydration status in young and active men and women compared to a control (water). The study will follow the same approach as used by Maughan and colleagues (2016) to measure the fluid balance (the difference between the amount of water consumed and passed as urine) and BHI (the relative amount of urine passed after consumption of a drink compared to water) including time in positive fluid balance, as well as determining electrolyte concentrations, osmolality, specific gravity, and sodium and potassium in urine.

Conditions

  • Hydration

Interventions

DIETARY_SUPPLEMENT

Multiplier

Subjects will consume 1 Liter (2 servings) of commercially available Hydration Multiplier product at a rate of 250 milliliters per 7.5 minutes.

DIETARY_SUPPLEMENT

Sugar Free

Subjects will consume 1 Liter (2 servings) of experimental Sugar Free Hydration Multiplier product at a rate of 250 milliliters per 7.5 minutes.

DIETARY_SUPPLEMENT

Sugar Free with Amino Acids

Subjects will consume 1 Liter (2 servings) of commercially available Sugar Free Hydration Multiplier product that contains amino acids at a rate of 250 milliliters per 7.5 minutes.

DIETARY_SUPPLEMENT

Water

Subjects will consume 1 Liter of water at a rate of 250 milliliters per 7.5 minutes.

Sponsors & Collaborators

  • University of Memphis

    lead OTHER

Principal Investigators

  • Richard Bloomer, PhD · Center for Nutraceutical and Dietary Supplement Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-23
Primary Completion
2024-09-06
Completion
2024-09-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06272435 on ClinicalTrials.gov